Number of biosimilars approved by PMDA Japan 2010-2019
收藏www.statista.com2024-01-09 更新2025-03-23 收录
下载链接：
https://www.statista.com/statistics/1118558/japan-pmda-approved-biosimilars/
下载链接
链接失效反馈官方服务：
资源简介：
In 2019, a total of eight new biosimilar medicines were approved by the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan, representing a peak in the last decade. Biosimilars refer to medical drugs that are equivalent or highly similar in quality to the biologic medical products that were already approved in the country. PMDA functions as a regulatory agency for pharmaceutical products and medical devices, working together with the health ministry in Japan.
2019年，日本药品医疗器械机构（PMDA）共批准了八种新的生物类似药，标志着过去十年来的一个高峰。生物类似药指的是与国家已批准的生物医疗产品在质量上等效或高度相似的药品。PMDA作为药品和医疗器械的监管机构，与日本健康部门协同工作。
提供机构：
Statista
